Dose adjustment in renal impairment: response from AHFS Drug Information
- PMID: 16052027
- PMCID: PMC1181276
- DOI: 10.1136/bmj.331.7511.293
Dose adjustment in renal impairment: response from AHFS Drug Information
Comment on
-
Systematic comparison of four sources of drug information regarding adjustment of dose for renal function.BMJ. 2005 Jul 30;331(7511):263. doi: 10.1136/bmj.38476.471088.3A. Epub 2005 May 19. BMJ. 2005. PMID: 15905228 Free PMC article.
References
-
- McEvoy GK, ed. AHFS drug information 2005. Bethesda, MD: American Society of Health-System Pharmacists, 2005.
-
- McEvoy GK. Drug information resources and medication safety. In: Manasse HR Jr, Thompson KK, eds. Medication safety: a guide for health care facilities. Bethesda, MD: American Society of Health-System Pharmacists; 2005: 253-74.
-
- US Food and Drug Administration Centers for Drug Evaluation and Research (CDER) and for Biologics Evaluation and Research (CBER). Guidance for industry: pharmacokinetics in patients with impaired renal function—study design, data analysis, and impact on dosing and labeling. Rockville, MD: US Department of Health and Human Services, 1998. Available at www.fda.gov/cder/guidance/index.htm
-
- McEvoy GK. Obtaining references for AHFS drug information monographs. Am J Hosp Pharm 1987;44: 1552.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical